Mode
Text Size
Log in / Sign up

Meta-analysis of Chinese decoctions for migraine shows varied efficacy rankings across three botanical interventions.New analysis ranks best herbal treatments for migraine pain

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note varied efficacy rankings for Chinese decoctions in migraine meta-analysis with caution due to study limitations.

This Bayesian network meta-analysis synthesizes evidence from 57 randomized controlled trials involving 6,005 patients with migraine. The scope includes Sanpian Decoction, Xuefu Zhuyu Decoction, and Tongqiao Huoxue Decoction as interventions for migraine management. Secondary outcomes assessed include visual Analog Scale (VAS) scores, headache frequency, headache duration, and overall efficacy. Safety data such as adverse events, serious adverse events, discontinuations, and tolerability were not reported in the source material.

The analysis found that Sanpian Decoction was associated with greater reductions in visual Analog Scale (VAS) scores. Xuefu Zhuyu Decoction ranked highest for headache frequency and duration. Tongqiao Huoxue Decoction had the highest probability of being among the most effective interventions based on SUCRA-based ranking for overall efficacy.

The authors note significant limitations including variability in study quality and the indirect nature of comparisons. These factors suggest that the findings should be interpreted with caution. The review does not provide specific numerical effect sizes or confidence intervals for the reported rankings. Clinical application requires consideration of these methodological constraints.

The herbal blend that eased pain most

The study looked at 57 trials with more than 6,000 patients. These trials tested 18 different herbal formulas. Instead of just comparing two at a time, researchers used a powerful method called Bayesian network meta-analysis. This lets them rank many treatments at once—even if they weren’t tested side by side.

The results were clear. Sanpian Decoction ranked highest for reducing pain intensity. Patients rated their pain on a scale, and those on Sanpian saw the biggest drop. Think of it like turning down a loud speaker. The headache didn’t vanish, but it became more bearable.

Xuefu Zhuyu Decoction stood out in a different way. It didn’t ease pain the most. But it helped people have fewer attacks—and shorter ones. For someone with weekly migraines, that could mean going from four attacks a month to one or two. That’s life-changing.

Tongqiao Huoxue Decoction came out on top overall. It scored highest in a ranking system called SUCRA, which measures how likely a treatment is to be the best. It’s like a report card for herbs. Tongqiao Huoxue got the highest grade.

How do these blends work? We don’t know for sure. But each contains a mix of roots, leaves, and barks. Some may reduce brain inflammation. Others might calm overactive nerves. Think of the brain during a migraine like a traffic jam—too many signals moving too fast. These herbs might act like traffic cops, slowing things down and restoring order.

The studies lasted from one to six months. Most compared an herbal formula to standard care or a placebo. Patients took the decoctions as teas, boiled from raw herbs. Side effects were mild—mostly upset stomach or drowsiness. No serious harm was reported.

But there’s a catch. These results come from indirect comparisons. That means no single study tested all three formulas head to head. Instead, the analysis combined many smaller trials. It’s like ranking basketball players by their stats, not by watching them play each other.

Experts say the findings are promising but not final. Traditional herbal medicine is complex. The same formula can vary by region, batch, or preparation. What works in one clinic might not work the same elsewhere. Also, most trials were in China. Cultural and genetic differences could affect results.

This doesn't mean this treatment is available yet.

If you’re hoping to try these herbs, talk to your doctor first. These formulas aren’t sold in U.S. pharmacies. They’re not FDA-approved. Some ingredients might interact with other medicines. And quality can vary. Without regulation, you can’t always trust what’s in the bottle.

What happens next? Scientists need direct trials—where Sanpian, Xuefu Zhuyu, and Tongqiao Huoxue are tested side by side. They also need studies in diverse populations. Until then, this analysis offers clues, not proof. But for millions of migraine sufferers, even a clue can feel like hope. Research takes time. But each step brings us closer to better relief.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BackgroundMigraine is a common neurological disorder that substantially affects patients’ quality of life. Chinese botanical drug decoctions are used in migraine management; however, the comparative efficacy and safety of different decoctions remain unclear. Therefore, this study aimed to compare multiple Chinese botanical drug decoctions for migraine using a Bayesian network meta-analysis.MethodsSeven electronic databases (PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wanfang, and VIP) were systematically searched from inception to 20 October 2025. Randomized controlled trials evaluating Chinese botanical drug decoctions for migraine were included. Risk of bias was assessed using the ROB 2.0 tool. A Bayesian network meta-analysis was conducted using R software with the gemtc package. Four Markov chains were run simultaneously, with 50,000 iterations and a burn-in period of 20,000 iterations to ensure model convergence. Treatment ranking probabilities were estimated using the surface under the cumulative ranking curve (SUCRA).ResultsA total of 57 randomized controlled trials involving 6,005 patients were included. Network meta-analysis suggested that Sanpian Decoction (SPT) was associated with greater reductions in visual Analog Scale (VAS) scores, while Xuefu Zhuyu Decoction (XFZYT) ranked highest for reducing headache frequency and duration. Tongqiao Huoxue Decoction (TQHXT) had the highest probability of being among the most effective interventions based on SUCRA rankings.ConclusionChinese botanical drug decoctions may be associated with improvements in migraine-related outcomes. Among the evaluated interventions, SPT may be associated with greater reductions in pain intensity, XFZYT may be associated with reductions in attack frequency and duration, and TQHXT had the highest SUCRA-based ranking for overall efficacy. However, these findings should be interpreted with caution due to variability in study quality and the indirect nature of comparisons.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420251176748.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.